VEGF inhibition and metastasis: possible implications for antiangiogenic therapy

Ítems similars

• VEGF(165)b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy
  per: Varey, A H R, et al.
  Publicat: (2008)
• Going beyond VEGF pathway inhibition for antiangiogenic cancer therapy: Is inhibition of the PP2A/B55α complex the answer?
  per: Martin, John D., et al.
  Publicat: (2020)
• Tie2 in Tumor Endothelial Signaling and Survival: Implications for Antiangiogenic Therapy
  per: Tsai, Jeff H., et al.
  Publicat: (2009)
• Significant addition to treatment options for bone metastasis in prostate cancer
  per: Richardson, Emily D., et al.
  Publicat: (2012)
• Beyond anti-VEGF: dual-targeting antiangiogenic and antiproliferative therapy
  per: Chen, Chun-Te, et al.
  Publicat: (2013)